Deficiency of PPARbeta/delta in the epidermis results in defective cutaneous permeability barrier homeostasis and increased inflammation.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Investigative Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17713572
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Harlequin ichthyosis and other autosomal recessive congenital ichthyoses: the underlying genetic defects and pathomechanisms.

  2006cited by this paper
• Topical treatment with thiazolidinediones, activators of peroxisome proliferator‐activated receptor‐γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model

  2006cited by this paper
• PPARbeta/delta selectively induces differentiation and inhibits cell proliferation.

  2006cited by this paper
• Regulation of ABCA1 expression in human keratinocytes and murine epidermis Published, JLR Papers in Press, July 6, 2006.

  2006cited by this paper
• Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing.

  2006cited by this paper
• Expression of Terminal Differentiation Proteins Defines Stages of Mouse Mammary Gland Development

  2006cited by this paper
• Harlequin ichthyosis unmasked: a defect of lipid transport.

  2005cited by this paper
• Peroxisome proliferator-activated receptor-beta/delta inhibits epidermal cell proliferation by down-regulation of kinase activity.

  2005cited by this paper
• Epithelium-mesenchyme interactions control the activity of peroxisome proliferator-activated receptor beta/delta during hair follicle development.

  2005cited by this paper
• Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation.

  2004cited by this paper
• Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes.

  2004cited by this paper
• Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin.

  2003cited by this paper
• p63 Is Expressed in Basal and Myoepithelial Cells of Human Normal and Tumor Salivary Gland Tissues

  2003cited by this paper
• Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.

  2003cited by this paper
• Role of peroxisome proliferator-activated receptor alpha in epidermal development in utero.

  2002cited by this paper
• Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.

  2002cited by this paper
• Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models.

  2002cited by this paper
• Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice

  2001cited by this paper
• Critical roles of PPAR beta/delta in keratinocyte response to inflammation.

  2001cited by this paper
• Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.

  2001cited by this paper
• Nuclear receptors and lipid physiology: opening the X-files.

  2001cited by this paper
• Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid.

  2001cited by this paper
• Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.

  2000cited by this paper
• Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ)

  2000cited by this paper
• Keratinocyte differentiation in hyperproliferative epidermis: topical application of PPARalpha activators restores tissue homeostasis.

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo.

  2000cited by this paper
• Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells.

  1999cited by this paper
• Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development.

  1998cited by this paper
• Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development.

  1998cited by this paper
• Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARalpha.

  1998cited by this paper
• Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes.

  1998cited by this paper
• Calcium and potassium inhibit barrier recovery after disruption, independent of the type of insult in hairless mice

  1997cited by this paper
• Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.

  1996cited by this paper
• The RXR heterodimers and orphan receptors.

  1995cited by this paper
• Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

  1995cited by this paper
• Fatty acids are required for epidermal permeability barrier function.

  1993cited by this paper
• Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.

  1993cited by this paper
• Lamellar body secretory response to barrier disruption.

  1992cited by this paper
• Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.

  1991cited by this paper
• Membrane structures in normal and essential fatty acid-deficient stratum corneum: characterization by ruthenium tetroxide staining and x-ray diffraction.

  1991cited by this paper
• Cholesterol synthesis is required for cutaneous barrier function in mice.

  1990cited by this paper

• Nuclear receptors for epidermal lipid barrier: Advances in mechanisms and applications

  2024cites this paper
• The Role of PGC-1α in Aging Skin Barrier Function

  2024cites this paper
• Activation of Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) in Keratinocytes by Endogenous Fatty Acids

  2024cites this paper
• ZFP750 affects the cutaneous barrier through regulating lipid metabolism

  2023cites this paper
• Horse-Derived Ceramide Accentuates Glucosylceramide Synthase and Ceramide Synthase 3 by Activating PPARβ/δ and/or PPARγ to Stimulate Ceramide Synthesis

  2023cites this paper
• PPARβ/δ Augments IL-1β-Induced COX-2 Expression and PGE2 Biosynthesis in Human Mesangial Cells via the Activation of SIRT1

  2022cites this paper
• FABP7 inhibits proliferation and invasion abilities of cutaneous squamous cell carcinoma cells via the Notch signaling pathway

  2022cites this paper
• The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.

  2021cites this paper
• Involvement of cutaneous SR-B1 in skin lipid homeostasis.

  2019cites this paper
• Congenital Recessive Ichthyosis : Studies of Gene Expressions Related to Keratinocyte Differentiation and Skin Barrier Repair

  2019influential citation
• Unraveling the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) expression in colon carcinogenesis

  2019cites this paper
• Regulatory mechanisms mediated by peroxisome proliferator‐activated receptor‐β/δ in skin cancer

  2019cites this paper
• Aster glehni Extract Containing Caffeoylquinic Compounds Protects Human Keratinocytes through the TRPV4-PPARδ-AMPK Pathway

  2018cites this paper
• Epigenetic Regulation of Skin Development and Regeneration

  2018cites this paper
• Identification of a novel PPAR beta / delta / miR-21-3 p axis in UV-induced skin inflammation

  2018cites this paper
• Local Burn Injury Promotes Defects in the Epidermal Lipid and Antimicrobial Peptide Barriers in Human Autograft Skin and Burn Margin: Implications for Burn Wound Healing and Graft Survival

  2017cites this paper
• Novel function of human beta-defensin 2 : protecting epidermal barrier against pathogenic proteases

  2017cites this paper
• Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis.

  2016cites this paper
• Commonly Employed African Neonatal Skin Care Products Compromise Epidermal Function in Mice

  2016cites this paper
• The role of barrier genes in epidermal malignancy

  2016cites this paper
• Hepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitro

  2016cites this paper
• Irritants and Skin Barrier Function.

  2016cites this paper
• Commonly Deployed Employed African Neonatal Skin Care Products Compromise Epidermal Function in Mice

  2016cites this paper
• Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes

  2016cites this paper
• Identification of a novel PPARβ/δ/miR‐21‐3p axis in UV‐induced skin inflammation

  2016cites this paper
• An optimized inexpensive emollient mixture improves barrier repair in murine skin

  2015cites this paper
• Nuclear receptor peroxisome proliferator activated receptor (PPAR) β/δ in skin wound healing and cancer

  2015cites this paper
• Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?

  2015cites this paper
• Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis.

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

  2014cites this paper
• Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation.

  2014cites this paper
• Epithelial-mesenchymal dialogue during skin wound healing

  2014cites this paper
• Ceramide synthesis in the epidermis.

  2014cites this paper
• Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation

  2013cites this paper
• Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis

  2013cites this paper
• Nrf2 links epidermal barrier function with antioxidant defense

  2012cites this paper
• Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4

  2012cites this paper
• Functional role of PPARδ in corneal epithelial wound healing.

  2012cites this paper
• Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients[S]

  2012cites this paper
• Expression of peroxisome proliferator activator receptor β/δ (PPARβ/δ) in acne vulgaris.

  2012cites this paper
• Regulation of permeability barrier homeostasis.

  2012cites this paper
• Abnormal epidermal barrier in the pathogenesis of atopic dermatitis.

  2012cites this paper
• Nukleäre Hormonrezeptoren: Perspektiven der Dermatotherapie

  2012cites this paper
• The mechanisms by which lipids coordinately regulate the formation of the protein and lipid domains of the stratum corneum

  2011cites this paper
• A topical Chinese herbal mixture improves epidermal permeability barrier function in normal murine skin

  2011cites this paper
• 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin alters sebaceous gland cell differentiation in vitro

  2011cites this paper
• Lipolysis – A highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores

  2011cites this paper
• Aquaporin-3 in keratinocytes and skin: its role and interaction with phospholipase D2.

  2011cites this paper
• PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis

  2011cites this paper
• Therapeutic Implications of a Barrier-Based Pathogenesis of Atopic Dermatitis

  2011cites this paper
• AP1‐dependent repression of TGFα‐mediated MMP9 upregulation by PPARδ agonists in keratinocytes

  2011cites this paper
• Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis

  2011cites this paper
• Phenotypic analysis of perennial airborne allergen‐specific CD4+ T cells in atopic and non‐atopic individuals

  2011cites this paper
• Phytoceramide and sphingoid bases derived from brewer's yeast Saccharomyces pastorianus activate peroxisome proliferator-activated receptors

  2011cites this paper
• Therapeutic Implications of a Barrier-based Pathogenesis of Atopic Dermatitis.

  2010cites this paper
• Epidermal Permeability Barrier Recovery Is Delayed in Vitiligo-Involved Sites

  2010cites this paper
• PPAR d Activation Promotes Stratum Corneum Formation and Epidermal Permeability Barrier Development during Late Gestation

  2010cites this paper
• A natural propenoic acid derivative activates peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).

  2010cites this paper
• IL-22 producing “T22” T-cells account for up-regulated IL-22 in atopic dermatitis (AD), despite reduced IL-17 producing Th17 T- cells

  2010cites this paper
• PPARδ activation promotes stratum corneum formation and epidermal permeability barrier development during late gestation.

  2010cites this paper
• IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.

  2009cites this paper
• Effects of a methanolic fraction of soybean seeds on the transcriptional activity of peroxisome proliferator-activated receptors (PPAR).

  2009cites this paper
• Non-invasive in vivo methods for investigation of the skin barrier physical properties.

  2009cites this paper
• Regulation of epithelial–mesenchymal IL-1 signaling by PPARβ/δ is essential for skin homeostasis and wound healing

  2009cites this paper
• Transcriptional Network of p63 in Human Keratinocytes

  2009cites this paper
• Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

  2009cites this paper
• Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens.

  2009cites this paper
• Abnormal skin barrier in the etiopathogenesis of atopic dermatitis

  2009cites this paper
• Sorting out the functional role(s) of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) in cell proliferation and cancer.

  2009cites this paper
• Sodium lauryl sulphate alters the mRNA expression of lipid‐metabolizing enzymes and PPAR signalling in normal human skin in vivo

  2009cites this paper
• Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

  2008cites this paper
• Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling.

  2008cites this paper
• Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms.

  2008cites this paper
• Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines.

  2008cites this paper
• Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines

  2008cites this paper
• Ligand Activation of Peroxisome Proliferator-Activated Receptor-β/δ Inhibits Cell Proliferation in Human HaCaT Keratinocytes

  2008cites this paper
• Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology Published, JLR Papers in Press, January 8, 2008.

  2008cites this paper
• Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

  2008cites this paper
• Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.

  2008cites this paper
• Ligand Activation of Peroxisome Proliferator–Activated Receptor b / d (PPAR b / d ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression

  2008cites this paper
• Regulation of Cell Proliferation and Differentiation by PPARβ/δ

  2008cites this paper
• AMPK and PPARd Agonists Are Exercise Mimetics

  2008cites this paper
• Regulation of ABCG1 expression in human keratinocytes and murine epidermis[S]

  2006cites this paper